| Financial Year |
March 31 2023 |
| Monetary Funds |
417,699,102.30 |
| Held-for-trading Financial Assets |
2,990,000.00 |
| Notes Receivable |
1,099,637.10 |
| Accounts Receivable |
334,317,468.63 |
| Advances to Suppliers |
19,485,214.83 |
| Other Receivables |
61,848,399.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
20,209,594.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
24,077,125.60 |
| Total Current Assets |
881,726,542.95 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,103,146,727.05 |
| Investment Properties |
8,913,944.65 |
| Fixed Assetes |
48,396,885.04 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,689,807.94 |
| R&D expenses |
489,246.03 |
| Goodwill |
615,584,368.17 |
| Long-Term Deferred and Prepaid Expenses |
6,546,457.24 |
| Deferred Income Tax Assets |
661,891.50 |
| Other Non-Current Assets |
3,176,001.90 |
| Sub-Total of Non-Current Assets |
1,996,755,362.13 |
| Total Assets |
2,878,481,905.08 |
| Short-Term Loans |
364,712.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
254,113,109.71 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
22,120,891.46 |
| Taxes Payable |
23,403,030.23 |
| Interest Payable |
-- |
| Dividend Payable |
7,768,642.48 |
| Other payables |
47,356,531.33 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,923,987.74 |
| Other Current Liabilities |
1,109,081.79 |
| Sub-Total of Current Liabilities |
382,966,052.60 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,618,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,026,554.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
22,321,950.48 |
| Total Liabilities |
405,288,003.08 |
| Paid-In Capital(Or Share Stock) |
1,654,585,820.00 |
| Capital Surplus |
7,050,138,728.36 |
| Surplus Reserve |
49,088,595.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-6,182,723,237.14 |
| Minority Stockholder's Interest |
52,221,270.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,420,972,631.22 |
| Owner's Equity（Stockholder's Equity） |
2,473,193,902.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,878,481,905.08 |
